论文部分内容阅读
据对农药产品登记动态资料统计,阿维菌素与哒螨灵复配,自1999年至2003年上半年登记3.2%至10.5%10种不同有效含量的制剂37个厂次,占复配制剂登记总量的8.6%。其中5%、10%分别登记14个厂次和10个厂次。占该组复配制剂登记总量的37.8%和27%,其他各种含量产品登记较为分散。在阿维菌素、哒螨灵参与组合的两类复配制剂中占有一定地位,排序均为第3位。该组制剂与阿维·毒制剂同年入市,在市场多品种竞争中,于2001年超前后,至今是阿维·毒制剂的123%。按生产企业所在区域统计,
According to statistics of pesticide product registration dynamic data, avermectin and pyridaben compound with registration of 3.2% to 10.5% from 1999 to the first half of 2003 10 different effective content of 37 formulations of plants, accounting for compounding formulations 8.6% of total registrations. Among them, 5% and 10% respectively register 14 plants and 10 plants. Accounting for 37.8% and 27% of the total amount of the compound preparations registered in this group. The registration of other kinds of products with different contents is relatively scattered. In the avermectin, pyridaben involved in the combination of two types of compound preparations occupy a certain position, ranked third. In the same year, the group entered into the market with Avi-Poison preparations in the same year and surpassed the 123% of Avi-Poisons preparations in the market competition in many varieties. According to the statistics of the region where the manufacturing enterprises are located,